Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

14.41
+0.41002.93%
Post-market: 14.450.0400+0.28%19:44 EDT
Volume:368.17K
Turnover:5.27M
Market Cap:1.33B
PE:-13.70
High:14.50
Open:14.00
Low:13.98
Close:14.00
52wk High:15.79
52wk Low:3.43
Shares:92.33M
Float Shares:63.79M
Volume Ratio:0.86
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0517
EPS(LYR):-0.5300
ROE:-141.68%
ROA:-25.71%
PB:30.20
PE(LYR):-27.19

Loading ...

Alpha Tau treats first patient with Alpha DaRT in Italy

TIPRANKS
·
May 08

Alpha Tau Medical Ltd: Successfully Treats First Pancreatic Cancer Patient in Italy With Alpha Dart

THOMSON REUTERS
·
May 07

Alpha Tau launches Italy feasibility study of Alpha DaRT in pancreatic cancer

Reuters
·
May 07

Alpha Tau to present Alpha DaRT-pembrolizumab head and neck cancer trial data at AHNS 2026

Reuters
·
May 05

Alpha Tau presents updated results from two clinical trials of Alpha DaRT

TIPRANKS
·
May 04

Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha Dart® Pancreatic Cancer Trials Presented at Ddw 2026

THOMSON REUTERS
·
May 04

Alpha Tau reports 100% local disease control in pooled Alpha DaRT pancreatic trials

Reuters
·
May 04

BRIEF-Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing

Reuters
·
Apr 28

Alpha Tau files $300M mixed securities shelf

TIPRANKS
·
Apr 28

Alpha Tau Medical Ltd - May Sell up to $100 Mln Ordinary Shares Under Equity Distribution Agreement - SEC Filing

THOMSON REUTERS
·
Apr 28

Alpha Tau pancreatic cancer Alpha DaRT pooled data accepted for ASCO presentation

Reuters
·
Apr 27

Alpha Tau says FDA approves IDE supplement expanding pancreatic cancer IMPACT trial

Reuters
·
Apr 23

Alpha Tau Announces FDA Approval of Ide Supplement to Expand Alpha Dart® Impact Trial to Patients With Pancreatic Cancer Receiving Gemcitabine With Abraxane® (Nab-Paclitaxel)

THOMSON REUTERS
·
Apr 23

Alpha Tau Medical Ltd - Impact Trial Expanded to Recruit Total of 40 Patients

THOMSON REUTERS
·
Apr 23

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe With Alpha Dart® in French Multicenter Acapella Clinical Trial

THOMSON REUTERS
·
Apr 23